The present invention relates to a vaccine for immunization against a viral infection caused by a hemorrhagic feline calicivirus (hFCV), a novel, atypical and unusually virulent form of a calicivirus that results in a highly contagious and fatal hemorrhagic fever syndrome. The present invention further encompasses methods of immunizing cats against particular strains of hFCV.

 
Web www.patentalert.com

< Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents

> Dihydroxypropyl cysteine peptide and agent containing this peptide

~ 00474